[1] GBD 2016 Dementia Collaborators. Global, regional, and national burden of alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol, 2019; 18, 88−106. doi:  10.1016/S1474-4422(18)30403-4
[2] Wu YT, Ali GC, Guerchet M, et al. Prevalence of dementia in mainland China, Hong Kong and taiwan: an updated systematic review and meta-analysis. Int J Epidemiol, 2018; 47, 709−19. doi:  10.1093/ije/dyy007
[3] McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to alzheimer's disease: recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for alzheimer's disease. Alzheim Dement, 2011; 7, 263−9. doi:  10.1016/j.jalz.2011.03.005
[4] McConathy J, Sheline YI. Imaging biomarkers associated with cognitive decline: a review. Biol Psychiatry, 2015; 77, 685−92. doi:  10.1016/j.biopsych.2014.08.024
[5] Kulic L, Unschuld PG. Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease. Curr Opin Neurol, 2016; 29, 749−55. doi:  10.1097/WCO.0000000000000399
[6] Kim HM, Han JW, Park YJ, et al. Association between retinal layer thickness and cognitive decline in older adults. JAMA Ophthalmol, 2022; 140, 683−90. doi:  10.1001/jamaophthalmol.2022.1563
[7] Noah AM, Almghairbi D, Moppett IK. Optical coherence tomography in mild cognitive impairment - systematic review and meta-analysis. Clin Neurol Neurosurg, 2020; 196, 106036. doi:  10.1016/j.clineuro.2020.106036
[8] Chan VTT, Sun ZH, Tang SM, et al. Spectral-domain oct measurements in alzheimer's disease: a systematic review and meta-analysis. Ophthalmology, 2019; 126, 497−510. doi:  10.1016/j.ophtha.2018.08.009
[9] Lian TH, Jin Z, Qu YZ, et al. The relationship between retinal nerve fiber layer thickness and clinical symptoms of alzheimer's disease. Front Aging Neurosci, 2021; 12, 584244. doi:  10.3389/fnagi.2020.584244
[10] Hughes AD, Falaschetti E, Witt N, et al. Association of retinopathy and retinal microvascular abnormalities with stroke and cerebrovascular disease. Stroke, 2016; 47, 2862−4. doi:  10.1161/STROKEAHA.116.014998
[11] István L, Czakó C, Élő Á, et al. Imaging retinal microvascular manifestations of carotid artery disease in older adults: from diagnosis of ocular complications to understanding microvascular contributions to cognitive impairment. Geroscience, 2021; 43, 1703−23. doi:  10.1007/s11357-021-00392-4
[12] Foster PJ, Atan D, Khawaja A, et al. Cohort profile: rationale and methods of uk biobank repeat imaging study eye measures to study dementia. BMJ Open, 2023; 13, e069258. doi:  10.1136/bmjopen-2022-069258
[13] Hilal S, Cheung CY, Wong TY, et al. Retinal parameters, cortical cerebral microinfarcts, and their interaction with cognitive impairment. Int J Stroke, 2023; 18, 70−7. doi:  10.1177/17474930221097737
[14] Zhou Y, Li Y, Xu L, et al. Asymptomatic polyvascular abnormalities in community (APAC) study in China: objectives, design and baseline characteristics. PLoS One, 2013; 8, e84685. doi:  10.1371/journal.pone.0084685
[15] Wang DD, Li Y, Zhou Y, et al. Asymptomatic carotid artery stenosis and retinal nerve fiber layer thickness. A community-based, observational study. PLoS One, 2017; 12, e0177277. doi:  10.1371/journal.pone.0177277
[16] Wong KS, Huang YN, Yang HB, et al. A door-to-door survey of intracranial atherosclerosis in Liangbei county, China. Neurology, 2007; 68, 2031−4. doi:  10.1212/01.wnl.0000264426.63544.ee
[17] Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: gray-scale and doppler US diagnosis--society of radiologists in ultrasound consensus conference. Radiology, 2003; 229, 340–6.
[18] Greenland P, Abrams J, Aurigemma GP, et al. Prevention conference v: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: writing Group III. Circulation, 2000; 101, E16−22.
[19] Zhang Q, Wang DD, Wang AX, et al. Relationship of ideal cardiovascular health metrics with retinal vessel calibers and retinal nerve fiber layer thickness: a cross-sectional study. BMC Cardiovasc Disord, 2018; 18, 187. doi:  10.1186/s12872-018-0922-1
[20] Zhang N, Yang Y, Wang A, et al. Association of ideal cardiovascular health metrics and cognitive functioning: the apac study. Eur J Neurol, 2016; 23, 1447−54. doi:  10.1111/ene.13056
[21] Li HZ, Jia JP, Yang ZQ. Mini-mental state examination in elderly chinese: a population-based normative study. J Alzheimers Dis, 2016; 53, 487−96. doi:  10.3233/JAD-160119
[22] Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975; 12, 189−98. doi:  10.1016/0022-3956(75)90026-6
[23] Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res, 2009; 43, 411−31. doi:  10.1016/j.jpsychires.2008.04.014
[24] Yatsuya H, Folsom AR, Wong TY, et al. Retinal microvascular abnormalities and risk of lacunar stroke: atherosclerosis risk in communities study. Stroke, 2010; 41, 1349−55. doi:  10.1161/STROKEAHA.110.580837
[25] Wang DD, Li Y, Wang CX, et al. Localized retinal nerve fiber layer defects and stroke. Stroke, 2014; 45, 1651−6. doi:  10.1161/STROKEAHA.113.004629
[26] Petzold A, Balcer LJ, Calabresi PA, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol, 2017; 16, 797−812. doi:  10.1016/S1474-4422(17)30278-8
[27] Chrysou A, Jansonius NM, Van Laar T. Retinal layers in parkinson's disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord, 2019; 64, 40−9. doi:  10.1016/j.parkreldis.2019.04.023
[28] Chang ZH, Xie F, Li HL, et al. Retinal nerve fiber layer thickness and associations with cognitive impairment in Parkinson's disease. front Aging Neurosci, 2022; 14, 832768. doi:  10.3389/fnagi.2022.832768
[29] Arnould L, Guillemin M, Seydou A, et al. Association between the retinal vascular network and retinal nerve fiber layer in the elderly: the montrachet study. PLoS One, 2020; 15, e0241055. doi:  10.1371/journal.pone.0241055
[30] Chua SYL, Lascaratos G, Atan D, et al. Relationships between retinal layer thickness and brain volumes in the uk biobank cohort. Eur J Neurol, 2021; 28, 1490−8. doi:  10.1111/ene.14706
[31] Lee MJ, Abraham AG, Swenor BK, et al. Application of optical coherence tomography in the detection and classification of cognitive decline. J Curr Glaucoma Pract, 2018; 12, 10−8. doi:  10.5005/jp-journals-10028-1238
[32] Van De Kreeke JA, Nguyen HT, Konijnenberg E, et al. Longitudinal retinal layer changes in preclinical Alzheimer's disease. Acta Ophthalmol, 2021; 99, 538−44. doi:  10.1111/aos.14640
[33] Ge YJ, Xu W, Ou YN, et al. Retinal biomarkers in alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis. Ageing Res Rev, 2021; 69, 101361. doi:  10.1016/j.arr.2021.101361
[34] Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab, 2016; 36, 172−86. doi:  10.1038/jcbfm.2015.164
[35] Kara B, Gordon MN, Gifani M, et al. Vascular and nonvascular mechanisms of cognitive impairment and dementia. Clin Geriatr Med, 2023; 39, 109−22. doi:  10.1016/j.cger.2022.07.006
[36] Yang Q, Wei XB, Deng B, et al. Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment. Neurobiol Dis, 2022; 170, 105750. doi:  10.1016/j.nbd.2022.105750
[37] Bell RD, Winkler EA, Sagare AP, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron, 2010; 68, 409−27. doi:  10.1016/j.neuron.2010.09.043
[38] Hao XL, Zhang WW, Jiao B, et al. Correlation between retinal structure and brain multimodal magnetic resonance imaging in patients with Alzheimer's disease. Front Aging Neurosci, 2023; 15, 1088829. doi:  10.3389/fnagi.2023.1088829
[39] O'Bryhim BE, Lin JB, Van Stavern GP, et al. OCT angiography findings in preclinical alzheimer's disease: 3-year follow-up. Ophthalmology, 2021; 128, 1489−91. doi:  10.1016/j.ophtha.2021.02.016
[40] O'Bryhim BE, Apte RS, Kung N, et al. Association of preclinical alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol, 2018; 136, 1242−8. doi:  10.1001/jamaophthalmol.2018.3556